Viewing Study NCT00431457



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00431457
Status: COMPLETED
Last Update Posted: 2023-01-25
First Post: 2007-02-02

Brief Title: Controlled Randomized Stimulation Versus Resection CoRaStiR
Sponsor: University Hospital Ghent
Organization: University Hospital Ghent

Study Overview

Official Title: Prospective Randomized Controlled Study of Neurostimulation in the Medial Temporal Lobe for Patients With Medically Refractory Medial Temporal Lobe Epilepsy Controlled Randomized Stimulation Versus Resection CoRaStiR
Status: COMPLETED
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients will be prospectively randomized to 3 different treatment arms

Treatment group 1 patients who undergo medial temporal lobe resection
Treatment group 2 patients who receive immediate hippocampal neurostimulation
Treatment group 3 patients who are implanted with an intracranial electrode but in whom hippocampal neurostimulation is delayed for 6 months

Twelve months after inclusion unblinding will occur Patients in group 2 and 3 will have the option to choose between continuing neurostimulation treatment or resective surgery

Study visits will occur every 3 months
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None